Close

Jefferies Lifts Price Target on Medivation (MDVN) to $105 Following Zytiga Data from ASCO

June 4, 2012 7:40 AM EDT Send to a Friend
Jefferies reiterated their Medivation (NASDAQ: MDVN) Buy rating and raised their price target to $105.00 from $97.00 following this weekend's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login